LIFEMD, INC. Accounts Receivable, Credit Loss Expense (Reversal)
LIFEMD, INC. (LFMD) reported Accounts Receivable, Credit Loss Expense (Reversal) of $133.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2022-03-07
- LIFEMD, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2021-06-30 was $0.00.
- LIFEMD, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2021-03-31 was $133.00K.
- LIFEMD, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2020-12-31 was $74.53K.
- LIFEMD, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- LIFEMD, INC. accounts receivable, credit loss expense (reversal) for fiscal 2020 was $133.00K.
- LIFEMD, INC. accounts receivable, credit loss expense (reversal) for fiscal 2017 was -$49.12K, a 169.05% decline from fiscal 2016.
- LIFEMD, INC. accounts receivable, credit loss expense (reversal) for fiscal 2016 was $71.14K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month as first filed |
|---|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $133.00K 10-Q · filed 2021-08-13 | $207.53K derived: sum of 3 quarters · filed 2022-03-07 | ||
| 2021-03-31 | $133.00K 10-Q · filed 2021-05-14 | $207.53K derived: sum of 2 quarters · filed 2022-03-07 | |||
| 2020-12-31 | $74.53K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $133.00K 10-K · filed 2022-03-07 | $133.47K 10-K · filed 2021-03-30 | ||
| 2020-09-30 | $58.47K 10-Q · filed 2021-11-10 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$4.58K derived: sum of 2 quarters · filed 2019-04-01 | -$11.09K derived: sum of 3 quarters · filed 2019-04-01 | -$49.12K 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$4.58K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2018-12-04 | -$11.09K derived: sum of 2 quarters · filed 2018-12-04 | -$49.12K 10-Q/A · filed 2018-12-04 | $65.58K derived: sum of 4 quarters · filed 2018-12-04 | |
| 2017-06-30 | -$6.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$44.54K 10-Q · filed 2018-08-17 | $70.15K derived: sum of 3 quarters · filed 2018-06-27 | ||
| 2017-03-31 | -$38.03K 10-Q · filed 2018-06-27 | $76.67K derived: sum of 2 quarters · filed 2018-06-27 | |||
| 2016-12-31 | $114.69K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $71.14K 10-K · filed 2018-04-02 | |||
| 2016-09-30 | -$43.56K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |